Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Mol Psychiatry ; 23(5): 1345-1355, 2018 05.
Article in English | MEDLINE | ID: mdl-28373690

ABSTRACT

Dietary intake of methyl donors, such as folic acid and methionine, shows considerable intra-individual variation in human populations. While it is recognized that maternal departures from the optimum of dietary methyl donor intake can increase the risk for mental health issues and neurological disorders in offspring, it has not been explored whether paternal dietary methyl donor intake influences behavioral and cognitive functions in the next generation. Here, we report that elevated paternal dietary methyl donor intake in a mouse model, transiently applied prior to mating, resulted in offspring animals (methyl donor-rich diet (MD) F1 mice) with deficits in hippocampus-dependent learning and memory, impaired hippocampal synaptic plasticity and reduced hippocampal theta oscillations. Gene expression analyses revealed altered expression of the methionine adenosyltransferase Mat2a and BK channel subunit Kcnmb2, which was associated with changes in Kcnmb2 promoter methylation in MD F1 mice. Hippocampal overexpression of Kcnmb2 in MD F1 mice ameliorated altered spatial learning and memory, supporting a role of this BK channel subunit in the MD F1 behavioral phenotype. Behavioral and gene expression changes did not extend into the F2 offspring generation. Together, our data indicate that paternal dietary factors influence cognitive and neural functions in the offspring generation.


Subject(s)
Cognition/physiology , Dietary Supplements/adverse effects , Paternal Inheritance/physiology , Animals , DNA Methylation , Diet , Epigenesis, Genetic , Fathers , Folic Acid/metabolism , Hippocampus/metabolism , Large-Conductance Calcium-Activated Potassium Channel beta Subunits , Learning/drug effects , Male , Memory/drug effects , Methionine/metabolism , Methionine Adenosyltransferase , Methylation , Mice , Mice, Inbred C57BL , Neurons/physiology , Paternal Inheritance/genetics , Promoter Regions, Genetic
2.
Neuroscience ; 205: 125-39, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22240250

ABSTRACT

Hippocampal theta oscillations are key elements in numerous behavioral and cognitive processes. Based on the dualistic theory of theta oscillations, one can differentiate between atropine-sensitive and atropine-insensitive theta subtypes. Urethane-induced atropine-sensitive theta oscillations are driven by muscarinic signal transduction pathways through G protein q/11 alpha subunit (Gα(q/11)), phospholipase ß( ») (PLCß( »), inositol trisphosphate (InsP3), diacylglycerole (DAG), and protein kinase C (PKC). Recent findings illustrate that Ca(v)2.3 Ca²âº channels are important targets of muscarinic signaling in the hippocampus mediating plateau potential generation, epileptiform burst activity, and complex rhythm generation in the septohippocampal network. To investigate the physiological implications of Ca(v)2.3 Ca²âº channels in hippocampal theta oscillations we performed radiotelemetric intrahippocampal (cornu ammonis (CA1)) recordings in urethane (800 mg/kg, i.p.) and atropine (50 mg/kg, i.p.) treated Ca(v)2.3⁺/⁺ and Ca(v)2.3⁻/⁻ mice followed by wavelet analysis of EEG data. Our results demonstrate that Ca(v)2.3 ablation, unlike PLCß1 deletion, does not result in complete abolishment of urethane-induced theta oscillations and that both mean and total theta duration is not significantly inhibited by subsequent atropine treatment, indicating that Ca(v)2.3 Ca²âº channels are important mediators of atropine-sensitive theta. Although theta frequency remained unchanged between both genotypes, the temporal characteristics of theta distribution, that is, theta architecture were significantly affected by the loss of Ca(v)2.3 Ca²âº channels. Our data suggest, for the first time, that Ca(v)2.3 voltage-gated Ca²âº channels (VGCC) are an important factor in septohippocampal synchronization associated with theta oscillation.


Subject(s)
Atropine/pharmacology , Biological Clocks/physiology , Calcium Channels, R-Type/physiology , Cation Transport Proteins/physiology , Hippocampus/metabolism , Theta Rhythm/physiology , Animals , Biological Clocks/drug effects , Calcium Channels, R-Type/deficiency , Calcium Channels, R-Type/genetics , Cation Transport Proteins/deficiency , Cation Transport Proteins/genetics , Hippocampus/drug effects , Hippocampus/physiology , Mice , Mice, Knockout , Signal Transduction/drug effects , Signal Transduction/genetics , Signal Transduction/physiology , Theta Rhythm/drug effects
3.
Nervenarzt ; 79(4): 426-36, 2008 Apr.
Article in German | MEDLINE | ID: mdl-18210049

ABSTRACT

Voltage-gated calcium channels are key components in a variety of physiological processes. Within the last decade an increasing number of voltage-gated Ca(2+) channelopathies in both humans and animal models has been described, most of which are related to the neurologic and muscular system. In humans, mutations were found in L-type Ca(v)1.2 and Ca(v)1.4 Ca(2+) channels as well as the non-L-type Ca(v)2.1 and T-type Ca(v)3.2 channels, resulting in altered electrophysiologic properties. Based on their widespread distribution within the CNS, voltage-gated calcium channels are of particular importance in the etiology and pathogenesis of various forms of epilepsy and neuropsychiatric disorders. In this review we characterise the different human Ca(2+) channelopathies known so far, further illuminating basic pathophysiologic mechanisms and clinical aspects.


Subject(s)
Calcium Channels/genetics , Channelopathies/genetics , DNA Mutational Analysis , Neuromuscular Junction Diseases/genetics , Calcium Channels/physiology , Channelopathies/diagnosis , Channelopathies/drug therapy , Genetic Counseling , Genetic Testing , Genetic Therapy , Humans , Neuromuscular Junction Diseases/diagnosis , Neuromuscular Junction Diseases/drug therapy
4.
Eur J Neurosci ; 21(6): 1617-25, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15845089

ABSTRACT

Ca2+ influx into excitable cells is a prerequisite for neurotransmitter release and regulated exocytosis. Within the group of ten cloned voltage-gated Ca2+ channels, the Ca(v)2.3-containing E-type Ca2+ channels are involved in various physiological processes, such as neurotransmitter release and exocytosis together with other voltage-gated Ca2+ channels of the Ca(v)1, Ca(v)2 and Ca(v)3 subfamily. However, E-type Ca2+ channels also exhibit several subunit-specific features, most of which still remain poorly understood. Ca(v)2.3-containing R-type channels (here called 'E-type channels') are also located in presynaptic terminals and interact with some synaptic vesicle proteins, the so-called SNARE proteins, although lacking the classical synprint interaction site. E-type channels trigger exocytosis and are also involved in long-term potentiation. Recently, it was shown that the interaction of Ca(v)2.3 with the EF-hand motif containing protein EFHC1 is involved in the aetiology and pathogenesis of juvenile myoclonic epilepsy.


Subject(s)
Calcium Channels/physiology , Cation Transport Proteins/physiology , Neurotransmitter Agents/metabolism , Presynaptic Terminals/physiology , Amino Acid Sequence , Animals , Calcium Channels, R-Type , Exocytosis/physiology , Humans , Long-Term Potentiation/physiology , Molecular Sequence Data , Neurotransmitter Agents/genetics , Protein Subunits/physiology
5.
Mol Pharmacol ; 60(5): 1121-32, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11641441

ABSTRACT

Inhibition of T-type Ca(2+) channels has been proposed to play a role in the therapeutic action of succinimide antiepileptic drugs. Despite the widespread acceptance of this hypothesis, recent studies using rat and cat neurons have failed to confirm inhibition of T-type currents at therapeutically relevant concentrations. The present study re-examines this issue using the three cloned human channels that constitute the T-type family: alpha 1G, alpha 1H, and alpha 1I. The cloned cDNAs were stably transfected and expressed into mammalian cells, leading to the appearance of typical T-type currents. The results demonstrate that both ethosuximide and the active metabolite of methsuximide, alpha-methyl-alpha-phenylsuccinimide (MPS), block human T-type channels in a state-dependent manner, with higher affinity for inactivated channels. In contrast, succinimide analogs that are not anticonvulsive were relatively poor blockers. The apparent affinity of MPS for inactivated states of the three channels was estimated using two independent measures: K(I) for alpha 1G and alpha 1I was 0.3 to 0.5 mM and for alpha 1H was 0.6 to 1.2 mM. T-type channels display current at the end of long pulses (persistent current), and this current was especially sensitive to block (ethosuximide IC(50) = 0.6 mM). These drugs also reduced both the size of the T-type window current region and the currents elicited by a mock low threshold spike. We conclude that succinimide antiepileptic drugs are capable of blocking human T-type channels at therapeutically relevant concentrations.


Subject(s)
Anticonvulsants/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels, T-Type/metabolism , Succinimides/pharmacology , Anticonvulsants/chemistry , Calcium Channel Blockers/chemistry , Calcium Channels, T-Type/drug effects , Calcium Channels, T-Type/genetics , Cloning, Molecular , DNA, Complementary/analysis , Electrophysiology , Ethosuximide/pharmacology , Humans , Structure-Activity Relationship , Succinimides/chemistry
6.
Eur J Biochem ; 268(4): 1066-75, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11179973

ABSTRACT

Among voltage-gated Ca2+ channels the non-dihydropyridine-sensitive alpha1E subunit is functionally less well characterized than the structurally related alpha1A (omega-agatoxin-IVA sensitive, P- /Q-type) and alpha1B (omega-conotoxin-GVIA sensitive, N-type) subunits. In the rat insulinoma cell line, INS-1, a tissue-specific splice variant of alpha1E (alpha1Ee) has been characterized at the mRNA and protein levels, suggesting that INS-1 cells are a suitable model for investigating the function of alpha1Ee. In alpha1E-transfected human embryonic kidney (HEK-293) cells the alpha1E-selective peptide antagonist SNX-482 (100 nM) reduces alpha1Ed- and alpha1Ee-induced Ba2+ inward currents in the absence and presence of the auxiliary subunits beta3 and alpha2delta-2 by more than 80%. The inhibition is fast and only partially reversible. No effect of SNX-482 was detected on the recombinant T-type Ca2+ channel subunits alpha1G, alpha1H, and alpha1I showing that the toxin from the venom of Hysterocrates gigas is useful as an alpha1E-selective antagonist. After blocking known components of Ca2+ channel inward current in INS-1 cells by 2 microM (+/-)-isradipine plus 0.5 microM omega-conotoxin-MVIIC, the remaining current is reduced by 100 nM SNX-482 from -12.4 +/- 1.2 pA/pF to -7.6 +/- 0.5 pA/pF (n = 9). Furthermore, in INS-1 cells, glucose- and KCl-induced insulin release are reduced by SNX-482 in a dose-dependent manner leading to the conclusion that alpha1E, in addition to L-type and non-L-type (alpha1A-mediated) Ca2+ currents, is involved in Ca2+ dependent insulin secretion of INS-1 cells.


Subject(s)
Calcium Channels, R-Type/physiology , Calcium Channels/physiology , Cation Transport Proteins , Insulin/metabolism , Insulinoma/metabolism , Islets of Langerhans/metabolism , Alternative Splicing , Animals , Barium/metabolism , Calcium Channel Blockers/pharmacology , Calcium Channels/genetics , Calcium Channels, R-Type/genetics , Cell Culture Techniques/methods , Cells, Cultured , Electric Conductivity , Glucose/pharmacology , Humans , Insulin Secretion , Islets of Langerhans/drug effects , Mice , Patch-Clamp Techniques , Potassium Chloride/pharmacology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Isoforms/physiology , Spider Venoms/pharmacology , Transfection , Tumor Cells, Cultured
7.
J Histochem Cytochem ; 48(6): 807-19, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10820154

ABSTRACT

The calcium channel alpha1E subunit was originally cloned from mammalian brain. A new splice variant was recently identified in rat islets of Langerhans and in human kidney by the polymerase chain reaction. The same isoform of alpha1E was detected in rat and guinea pig heart by amplifying indicative cDNA fragments and by immunostaining using peptide-specific antibodies. The apparent molecular size of cardiac alpha1E was determined by SDS-PAGE and immunoblotting (218 +/- 6 kD; n = 3). Compared to alpha1E from stably transfected HEK-293 cells, this is smaller by 28 kD. The distribution of alpha1E in cardiac muscle cells of the conducting system and in the cardiomyoblast cell line H9c2 was compared to the distribution of chromogranin, a marker of neuroendocrine cells, and to the distribution of atrial natriuretic peptide (ANP). In serial sections from atrial and ventricular regions of rat heart, co-localization of alpha1E with ANP was detected in atrium and with chromogranin A/B in Purkinje fibers of the conducting system in both rat atrium and ventricle. The kidney is another organ in which natriuretic peptide hormones are secreted. The detection of alpha1E in the distal tubules of human kidney, where urodilatin is stored and secreted, led to the conclusion that the expression of alpha1E in rat heart and human kidney is linked to regions with endocrine functions and therefore is involved in the Ca(2+)-dependent secretion of peptide hormones such as ANP and urodilatin.


Subject(s)
Calcium Channels, T-Type/analysis , Chromogranins/metabolism , Ion Channel Gating , Kidney Tubules, Distal/chemistry , Myocardium/chemistry , Alternative Splicing , Amino Acid Sequence , Animals , Antibody Specificity , Brain/metabolism , Brain/pathology , Calcium Channels, T-Type/genetics , Calcium Channels, T-Type/immunology , Cell Line, Transformed , Female , Guinea Pigs , Humans , Immunoblotting/methods , Immunohistochemistry/methods , Intracellular Membranes/chemistry , Kidney Tubules, Distal/cytology , Membrane Proteins/analysis , Microsomes/chemistry , Molecular Sequence Data , Myocardium/cytology , Rats , Rats, Wistar , Sequence Homology, Amino Acid , Tumor Cells, Cultured
8.
J Histochem Cytochem ; 47(8): 981-94, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10424882

ABSTRACT

Polyclonal antibodies were raised against a common and a specific epitope present only in longer alpha1E isoforms of voltage-gated Ca(2+) channels, yielding an "anti-E-com" and an "anti-E-spec" serum, respectively. The specificity of both sera was established by immunocytochemistry and immunoblotting using stably transfected HEK-293 cells or membrane proteins derived from them. Cells from the insulinoma cell line INS-1, tissue sections from cerebellum, and representative regions of gastrointestinal tract were stained immunocytochemically. INS-1 cells expressed an alpha1E splice variant with a longer carboxy terminus, the so-called alpha1Ee isoform. Similarily, in rat cerebellum, which was used as a reference system, the anti-E-spec serum stained somata and dendrites of Purkinje cells. Only faint staining was seen throughout the cerebellar granule cell layer. After prolonged incubation times, neurons of the molecular layer were stained by anti-E-com, suggesting that a shorter alpha1E isoform is expressed at a lower protein density. In human gastrointestinal tract, endocrine cells of the antral mucosa (stomach), small and large intestine, and islets of Langerhans were stained by the anti-E-spec serum. In addition, staining by the anti-E-spec serum was observed in Paneth cells and in the smooth muscle cell layer of the lamina muscularis mucosae. We conclude that the longer alpha1Ee isoform is expressed in neuroendocrine cells of the digestive system and that, in pancreas, alpha1Ee expression is restricted to the neuroendocrine part, the islets of Langerhans. alpha1E therefore appears to be a common voltage-gated Ca(2+) channel linked to neuroendocrine and related systems of the body.


Subject(s)
Calcium Channels/metabolism , Cerebellum/metabolism , Digestive System/metabolism , Islets of Langerhans/metabolism , Animals , Antibody Specificity , Calcium Channels/immunology , Humans , Insulinoma/metabolism , Protein Isoforms/immunology , Protein Isoforms/metabolism , Rats , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...